Loading…
Reported covered position: Senate Finance: Senior Health Policy Advisor-Chair; Senior Health Policy Advisor-RM; Health Policy Advisor-RM; Deputy Legislative Director-Senate; Legislative Assistant-Senate; Deputy Legislative Assistant-Senate; Legislative Fellow-Senate
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Accelerating Kids’ Access to Care Act of 2025
Client: ORCHARD THERAPEUTICS NORTH AMERICA · Firm: LEAVITT PARTNERS, LLC
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).
Accelerating Kids’ Access to Care Act of 2025
Client: ORCHARD THERAPEUTICS NORTH AMERICA · Firm: LEAVITT PARTNERS, LLC
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (ON BEHALF OF THE PHARMACY COALITION) via LEAVITT PARTNERS, LLC
2026 · third_quarter · Q3
Implementation of section 6223 of the Consolidated Appropriations Act, 2026
Implementation of section 6223 of the Consolidated Appropriations Act, 2026
Source: Senate LDA
Accelerating Kids’ Access to Care Act of 2025
Client: ORCHARD THERAPEUTICS NORTH AMERICA · Firm: LEAVITT PARTNERS, LLC
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).
Accelerating Kids’ Access to Care Act
Client: ORCHARD THERAPEUTICS NORTH AMERICA · Firm: LEAVITT PARTNERS, LLC
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).
Accelerating Kids’ Access to Care Act
Client: ORCHARD THERAPEUTICS NORTH AMERICA · Firm: LEAVITT PARTNERS, LLC
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).
Accelerating Kids’ Access to Care Act
Client: ORCHARD THERAPEUTICS NORTH AMERICA · Firm: LEAVITT PARTNERS, LLC
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).
Accelerating Kids’ Access to Care Act of 2025
Client: ORCHARD THERAPEUTICS NORTH AMERICA · Firm: LEAVITT PARTNERS, LLC
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).
Accelerating Kids’ Access to Care Act of 2025
Client: ORCHARD THERAPEUTICS NORTH AMERICA · Firm: LEAVITT PARTNERS, LLC
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).
Accelerating Kids’ Access to Care Act of 2025
Client: ORCHARD THERAPEUTICS NORTH AMERICA · Firm: LEAVITT PARTNERS, LLC
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).
Accelerating Kids’ Access to Care Act
Client: ORCHARD THERAPEUTICS NORTH AMERICA · Firm: LEAVITT PARTNERS, LLC
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).
Accelerating Kids’ Access to Care Act
Client: ORCHARD THERAPEUTICS NORTH AMERICA · Firm: LEAVITT PARTNERS, LLC
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).
Accelerating Kids’ Access to Care Act
Client: ORCHARD THERAPEUTICS NORTH AMERICA · Firm: LEAVITT PARTNERS, LLC
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).
Implementation of section 6223 of the Consolidated Appropriations Act, 2026
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (ON BEHALF OF THE PHARMACY COALITION) via LEAVITT PARTNERS, LLC
2026 · third_quarter · RR
Implementation of section 6223 of the Consolidated Appropriations Act, 2026
Implementation of section 6223 of the Consolidated Appropriations Act, 2026
Implementation of section 6223 of the Consolidated Appropriations Act, 2026
ORCHARD THERAPEUTICS NORTH AMERICA via LEAVITT PARTNERS, LLC
2026 · third_quarter · Q3
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ORCHARD THERAPEUTICS NORTH AMERICA via LEAVITT PARTNERS, LLC
2026 · second_quarter · Q2
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ORCHARD THERAPEUTICS NORTH AMERICA via LEAVITT PARTNERS, LLC
2026 · first_quarter · Q1
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ORCHARD THERAPEUTICS NORTH AMERICA via LEAVITT PARTNERS, LLC
2025 · fourth_quarter · Q4
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORCHARD THERAPEUTICS NORTH AMERICA via LEAVITT PARTNERS, LLC
2025 · third_quarter · Q3
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORCHARD THERAPEUTICS NORTH AMERICA via LEAVITT PARTNERS, LLC
2025 · second_quarter · RA
Newborn screening and pharmaceuticals.
ORCHARD THERAPEUTICS NORTH AMERICA via LEAVITT PARTNERS, LLC
2025 · second_quarter · Q2
Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORCHARD THERAPEUTICS NORTH AMERICA via LEAVITT PARTNERS, LLC
2025 · second_quarter · RR
Newborn screening and pharmaceuticals.